Skip to content

Magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide

C30H33BrMgN10O2 — CID 158101303

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACmagnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide
SMILESCC(O)c1cnn(Cc2nc3ccc(C4CC4)cn3n2)c1.O=Cc1cn(Cc2cn3cc(C4CC4)ccc3n2)nn1.[Br-].[CH3-].[Mg+2]
InChIInChI=1S/C15H17N5O.C14H13N5O.CH3.BrH.Mg/c1-10(21)13-6-16-19(7-13)9-14-17-15-5-4-12(11-2-3-11)8-20(15)18-14;20-9-13-8-19(17-16-13)7-12-6-18-5-11(10-1-2-10)3-4-14(18)15-12;;;/h4-8,10-11,21H,2-3,9H2,1H3;3-6,8-10H,1-2,7H2;1H3;1H;/q;;-1;;+2/p-1
InChIKeySNZGRSIZYUJPRO-UHFFFAOYSA-M
MW669.87 g/mol
LogP0.64
Rot. Bonds8

About Magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide

Magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide (PubChem CID 158101303) has the molecular formula C30H33BrMgN10O2 and a molecular weight of 669.87 g/mol. Its IUPAC name is magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide.

Molecular Properties

Compound NameMagnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide
PubChem CID158101303
Molecular FormulaC30H33BrMgN10O2
Molecular Weight669.87 g/mol
Exact Mass668.18
IUPAC Namemagnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide
SMILESCC(O)c1cnn(Cc2nc3ccc(C4CC4)cn3n2)c1.O=Cc1cn(Cc2cn3cc(C4CC4)ccc3n2)nn1.[Br-].[CH3-].[Mg+2]
InChIInChI=1S/C15H17N5O.C14H13N5O.CH3.BrH.Mg/c1-10(21)13-6-16-19(7-13)9-14-17-15-5-4-12(11-2-3-11)8-20(15)18-14;20-9-13-8-19(17-16-13)7-12-6-18-5-11(10-1-2-10)3-4-14(18)15-12;;;/h4-8,10-11,21H,2-3,9H2,1H3;3-6,8-10H,1-2,7H2;1H3;1H;/q;;-1;;+2/p-1
InChIKeySNZGRSIZYUJPRO-UHFFFAOYSA-M
XLogP0.64
TPSA133.32 Ų
H-Bond Donors1
H-Bond Acceptors12
Rotatable Bonds8
Heavy Atoms44
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500669.87
LogP ≤ 50.64
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze Magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide?
The IUPAC name of Magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide (CID 158101303) is magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide.
What is the SMILES notation for Magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide?
The canonical SMILES for Magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide is CC(O)c1cnn(Cc2nc3ccc(C4CC4)cn3n2)c1.O=Cc1cn(Cc2cn3cc(C4CC4)ccc3n2)nn1.[Br-].[CH3-].[Mg+2].
What is the InChIKey of Magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide?
The InChIKey is SNZGRSIZYUJPRO-UHFFFAOYSA-M. The full InChI is InChI=1S/C15H17N5O.C14H13N5O.CH3.BrH.Mg/c1-10(21)13-6-16-19(7-13)9-14-17-15-5-4-12(11-2-3-11)8-20(15)18-14;20-9-13-8-19(17-16-13)7-12-6-18-5-11(10-1-2-10)3-4-14(18)15-12;;;/h4-8,10-11,21H,2-3,9H2,1H3;3-6,8-10H,1-2,7H2;1H3;1H;/q;;-1;;+2/p-1.
What are the key properties of Magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide?
Magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide has a molecular weight of 669.87 g/mol, XLogP of 0.64, 8 rotatable bonds, 1 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for Magnesium;carbanide;1-[(6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl]triazole-4-carbaldehyde;1-[1-[(6-cyclopropyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)methyl]pyrazol-4-yl]ethanol;bromide is sourced from PubChem (CID 158101303), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.